Last reviewed · How we verify
IBI308\cisplatin\gemcitabine
IBI308\cisplatin\gemcitabine is a Small molecule drug developed by Innovent Biologics (Suzhou) Co. Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | IBI308\cisplatin\gemcitabine |
|---|---|
| Sponsor | Innovent Biologics (Suzhou) Co. Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma (PHASE3)
- Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC (PHASE3)
- First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors (PHASE1)
- Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer (PHASE2)
- PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IBI308\cisplatin\gemcitabine CI brief — competitive landscape report
- IBI308\cisplatin\gemcitabine updates RSS · CI watch RSS
- Innovent Biologics (Suzhou) Co. Ltd. portfolio CI
Frequently asked questions about IBI308\cisplatin\gemcitabine
What is IBI308\cisplatin\gemcitabine?
IBI308\cisplatin\gemcitabine is a Small molecule drug developed by Innovent Biologics (Suzhou) Co. Ltd..
Who makes IBI308\cisplatin\gemcitabine?
IBI308\cisplatin\gemcitabine is developed by Innovent Biologics (Suzhou) Co. Ltd. (see full Innovent Biologics (Suzhou) Co. Ltd. pipeline at /company/innovent-biologics-suzhou-co-ltd).
What development phase is IBI308\cisplatin\gemcitabine in?
IBI308\cisplatin\gemcitabine is in Phase 1.